Ability (ABILF) Stock Price, News & Analysis

Company Overview

Ability Inc. (OTCMKTS: ABILF) is a contract development and manufacturing organization (CDMO) based in South Korea that provides integrated services for the biopharmaceutical industry. The company focuses on microbial and mammalian cell line development, process optimization, scale-up manufacturing and quality control testing under current Good Manufacturing Practice (cGMP) conditions.

Its service portfolio covers upstream and downstream process development, analytical method development and validation, as well as fill–finish operations for recombinant proteins and biologics. By leveraging its in-house bioreactor capacity and analytical laboratories, Ability supports clients in navigating regulatory requirements and advancing candidates from preclinical stages through commercial production.

Ability serves a diverse client base across Asia, North America and Europe, collaborating with emerging biotech firms and established pharmaceutical companies. The company’s facilities are equipped to handle a range of scales, from pilot batches to commercial volumes, and adhere to international quality standards. Through strategic partnerships and technology investments, Ability strives to address global demand for outsourced biomanufacturing solutions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 19 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Technology
• Industry: Electronic Equipment, Instruments & Components
• Sub-Industry: Electronic Equipment & Instruments
• Current Symbol: OTCMKTS:ABILF
• CIK: 1652866
• Web: www.interceptors.com
• Phone: (723) 687-9777
• Fax: 972-3537-6483
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -434.07